SonoSite Introduces the 6 lb. NanoMaxx - A Breakthrough Ultrasound Tool Aimed at ReducingPatient Safety Risks and Healthcare Delivery Costs

One Button User Interface, High Resolution Imaging
International Shipments Begun

BOTHELL, Wash.--(Business Wire)--
SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried
ultrasound, today announced the introduction of its new 6 pound NanoMaxx
ultrasound tool, the latest addition to SonoSite`s suite of specialized products
for point-of-care visualization in medicine. Designed for diagnostic imaging,
clinical assessment and procedural guidance at the hospital bedside and in the
physician`s office, the NanoMaxx system is the company`s latest innovation in
point-of-care user design and features one button system control. SonoSite has
begun deliveries to international customers and is waiting FDA 510(k) clearance
to begin US customer shipments.

"The NanoMaxx tool makes high-quality ultrasound available to a much broader
range of clinicians and applications, all of which can save time and money and
improve patient safety," said Kevin M. Goodwin, SonoSite President and CEO. "The
healthcare world is changing dramatically, and the NanoMaxx is part of our
continuing effort to make ultrasound a more affordable and useful tool in the
world of medicine."

"The NanoMaxx system offers our gold standard durability and two-hour battery
life along with image quality similar to our flagship M-Turbo system. A
fluid-resistant user interface makes the system easy to clean and disinfect,
helping to address the growing concern over infection control. Designed and
manufactured at SonoSite`s headquarters in Bothell, Washington, USA, the
NanoMaxx system and its transducers again offer our industry-leading 5-year
warranty to deliver the lowest cost of ownership in ultrasound," Mr. Goodwin
said.

One Button Technology Optimizes Workflow

Based on SonoSite`s 4th generation Turbo technology platform, the NanoMaxx
system incorporates proprietary, advanced imaging algorithm technologies,
including ColorHD to deliver exceptional image quality in a lightweight, rugged
form factor.

With a touch screen that responds easily to the tap of a finger, and one button
optimization, clinicians can readily acquire high resolution images to increase
clinical productivity at the point-of-care. A system boot-up time of less than
20 seconds and long battery life further enhance workflow when using the
NanoMaxx system.

Designed to Help Hospitals Meet New Standards of Care

Clinical studies have proven that bedside ultrasound increases the accuracy of
interventional procedures, and it is now recommended by two government-based
agencies1 and three US medical societies.2 At introduction, the NanoMaxx tool is
available with a complement of five transducers to support a wide range of
examinations and procedures including thoracic assessment for hemothorax,
hydrothorax and pneumothorax, vascular access, needle aspirations and
injections, as well as abdominal, cardiac, nerve, OB/Gyn, musculoskeletal, small
parts and vascular scanning.

The clinical capabilities of the NanoMaxx will help eliminate the risk and cost
of transporting patients to the imaging lab for many examinations and
procedures.

Mount it.Carry it.Or Use it on a Stand

The small footprint of the NanoMaxx system, along with its space-saving
solutions, enables seamless integration with a variety of exam-room
configurations. It can be wall mounted, placed on an exam table, or used from a
highly maneuverable stand. Physicians can easily carry the NanoMaxx tool from
room-to-room, to a satellite office, the operating room or to a field site for
immediate use.

Built to Last

The NanoMaxx system`s highly integrated architecture and ruggedized design,
including the industry`s first elastomeric bumper for extra durability, allows
it to be used in the most austere and demanding environments. A magnesium shell
that is significantly stronger and lighter than plastic helps to protect the
system against accidental droppage. As with all SonoSite systems, the NanoMaxx
ultrasound tool and its transducers are built to withstand a one meter drop
test.

Web-Based Demonstration and Purchasing Program

SonoSite`s One-to-One Purchase Program further extends the cost-saving
advantages of the NanoMaxx ultrasound tool by replacing or complementing the
traditional on-site, pre-sale demonstration with a personal phone consultation
and webcast demonstration provided by a professional clinical sales consultant.
Visit the NanoMaxx ultrasound tool website to learn more about SonoSite`s newest
system and to experience a personal, interactive product demo. In addition,
Apple iPhone and iPod mobile device users can view a video of the NanoMaxx
system on SonoSite`s new SonoAccess application.

About SonoSite

SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in
hand-carried ultrasound. Headquartered near Seattle, the company is represented
by ten subsidiaries and a global distribution network in over 100 countries.
SonoSite`s small, lightweight systems are expanding the use of ultrasound across
the clinical spectrum by cost-effectively bringing high-performance ultrasound
to the point of patient care. The company employs approximately 700 people
worldwide.

Forward-looking Information and the Private Litigation Reform Act of 1995

Certain statements in this press release relating to the market acceptance of
our products, possible future sales relating to expected orders, and our future
financial position and operating results are "forward-looking statements" for
the purposes of the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based on the opinions
and estimates of our management at the time the statements are made and are
subject to risks and uncertainties that could cause actual results to differ
materially from those expected or implied by the forward-looking statements.
These statements are not guaranties of future performance and are subject to
known and unknown risks and uncertainties and are based on potentially
inaccurate assumptions. Factors that could affect the rate and extent of market
acceptance of our products, the receipt of expected orders, and our financial
performance include our ability to successfully manufacture, market and sell our
ultrasound systems, our ability to accurately forecast customer demand for our
products, our customers` ability to finance the purchase of our systems,
including the effect of reduced spending by hospitals, our ability to
manufacture and ship our systems in a timely manner to meet customer demand,
variability in quarterly results caused by the timing of large project orders
from governmental or international entities and the seasonality of hospital
purchasing patterns, timely receipts of regulatory approvals to market and sell
our products, regulatory and reimbursement changes in various national health
care markets, constraints in government and public health spending, the ability
of our distribution partners and other sales channels to market and sell our
products and any changes to such channels, the impact of patent litigation, our
ability to execute our acquisition strategy and effectively integrate acquired
products and operations, the effect of transactions and activities associated
with our issuance of senior convertible debt in July 2007, including a
repurchase of a portion of the debt, on the market price of our common stock,
and as well as other factors contained in the Item 1A. "Risk Factors" section of
our most recent Annual Report on Form 10-K filed with the Securities and
Exchange Commission. We caution readers not to place undue reliance upon these
forward-looking statements that speak only as to the date of this release. We
undertake no obligation to publicly revise any forward-looking statements to
reflect new information, events or circumstances after the date of this release
or to reflect the occurrence of unanticipated events.

iPhone is a trademark of Apple, Inc.

1 Agency for Health Care Research and Quality (AHRQ) report: Making Healthcare
Safer: A Critical Analysis of Patient Safety Practices 2001.

National Institute for Clinical Excellence (NICE) report: Guidance on the Use of
Ultrasound Locating Devices for Placing Central Venous Catheters. 2002.

2 The American Board of Internal Medicine. "Training and Procedural
Requirements; Critcial Care Medicine." Critical Care MedicinePolicies. 2009. The
American Board of Internal Medicine. .

The American College of Chest Physicians. "Consensus Statement; La Societe de
Reanimation de Langue Francaise Statement on Competence in Critcial Care
Ultrasonography." 135 (2009): 1050-1060.

The American College of Emergency Physicians."Policy Statement; Emergency
Ultrasound Guidelines." 53 (2009): 550-70.

SonoSite, Inc.
Anne Bugge, 425-951-1378

Copyright Business Wire 2009